136 related articles for article (PubMed ID: 7857338)
21. Pidotimod. A new biological response modifier. Introduction.
Maillard F
Arzneimittelforschung; 1994 Dec; 44(12A):1399-401. PubMed ID: 7857330
[No Abstract] [Full Text] [Related]
22. Protective effects of pidotimod against experimental bacterial infections in mice.
Coppi G; Falcone A; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and preliminary pharmacological evaluation of pidotimod, its enantiomer, diastereomers and carboxamido derivatives.
Magni A; Signorelli G; Bocchiola G
Arzneimittelforschung; 1994 Dec; 44(12A):1402-4. PubMed ID: 7857331
[TBL] [Abstract][Full Text] [Related]
25. Effect of food on the bioavailability of pidotimod in healthy volunteers.
D'Angelo L; De Ponti F; Crema F; Caravaggi M; Crema A
Arzneimittelforschung; 1994 Dec; 44(12A):1473-5. PubMed ID: 7857345
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of pidotimod in elderly volunteers and in renal failure patients.
Spotti D; Biffi M; Coppi G; Silingardi S; Mailland F
Arzneimittelforschung; 1994 Dec; 44(12A):1470-2. PubMed ID: 7857344
[TBL] [Abstract][Full Text] [Related]
27. Pidotimod in the treatment of recurrent respiratory infections in paediatric patients.
Careddu P; Mei V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1485-9. PubMed ID: 7857348
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the cocaine-amphetamine regulated transcript peptide (CART 55-102) in the modulation of rat immune cell activity.
Bik W; Skwarlo-Sonta K; Szelagiewicz J; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska-Bik A; Baranowska B
Neuro Endocrinol Lett; 2008 Jun; 29(3):359-65. PubMed ID: 18580846
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children.
Clemente E; Solli R; Mei V; Cera R; Caramia G; Carnelli V; Ruffini E; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1490-4. PubMed ID: 7857349
[TBL] [Abstract][Full Text] [Related]
30. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
31. Pidotimod activity against chronic bronchitis exacerbations.
Ciaccia A
Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
[TBL] [Abstract][Full Text] [Related]
32. [Pidotimod, a new biological response modifier, is able to partially prevent immune response changes related to surgical stress].
Pasqui AL; Bruni F; Di Renzo M; Saletti M; Bova G; Gotti G; Auteri A
Drugs Exp Clin Res; 1993; 19 Suppl():45-53. PubMed ID: 8625782
[No Abstract] [Full Text] [Related]
33. A new HPLC method for pidotimod plasma levels determination.
Dal Bo L; Broccali GP; Silingardi S; Coppi G
Boll Chim Farm; 1993 Apr; 132(4):126-8. PubMed ID: 8333918
[TBL] [Abstract][Full Text] [Related]
34. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
Pozzi E; Dolcetti A; Orlandi O; Cirianni C; Moreo G; Piacenza G; Rampulla C; Fugazza L; Scarpazza G
Arzneimittelforschung; 1994 Dec; 44(12A):1495-8. PubMed ID: 7857350
[TBL] [Abstract][Full Text] [Related]
35. Immunoactivity of pidotimod against episodes of recurrent tonsillitis in childhood.
Motta G; De Campora E; De Vita C; Esposito S; Galletti C; Incutti V; Mallardi V; Motta S; Pucci V; Salonna F
Arzneimittelforschung; 1994 Dec; 44(12A):1521-4. PubMed ID: 7857356
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and oral bioavailability of pidotimod in humans.
Mailland F; Coppi G; Silingardi S
Arzneimittelforschung; 1994 Dec; 44(12A):1465-9. PubMed ID: 7857343
[TBL] [Abstract][Full Text] [Related]
37. Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood.
Careddu P
Arzneimittelforschung; 1994 Dec; 44(12A):1506-11. PubMed ID: 7857353
[TBL] [Abstract][Full Text] [Related]
38. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
Barchielli M; Coppi G
Acta Physiol Hung; 1990; 75 Suppl():25-6. PubMed ID: 2371881
[No Abstract] [Full Text] [Related]
39. Genotoxicity testing of pidotimod in vitro and in vivo.
Adams K; Allen JA; Brooker PC; Henderson L; Jones E; Proudlock RJ; Mailland F; Coppi G
Arzneimittelforschung; 1994 Dec; 44(12A):1454-9. PubMed ID: 7857341
[TBL] [Abstract][Full Text] [Related]
40. [Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs].
Vacca A; Di Stefano R; Caloro D; Ranieri G; Dammacco F
Drugs Exp Clin Res; 1993; 19 Suppl():23-6. PubMed ID: 8625779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
